A transgenic mouse expressing miR‐210 in proximal tubule cells shows mitochondrial alteration: possible association of miR‐210 with a shift in energy metabolism
Authors:
- 19 February 2020
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 251 (1) , 12-25
Abstract
Previously we reported that the microRNA miR‐210 is aberrantly upregulated in clear cell renal cell carcinoma (ccRCC) via deregulation of the VHL–HIF pathway. In the present study, to investigate the biological impact of miR‐210 in ccRCC tumorigenesis, we developed a transgenic mouse line expressing miR‐210 in proximal tubule cells under control of the mouse SGLT2/Slc5a2 promoter. Light microscopy revealed desquamation of the tubule cells and regeneration of the proximal tubule, suggesting that miR‐210 expression led to damage of the proximal tubule cells. Electron microscopy revealed alterations to the mitochondria in proximal tubule cells, with marked reduction of the mitochondrial inner membrane, which is the main site of ATP production via oxidative phosphorylation (OxPhos). An additional in vitro study revealed that this loss of the inner membrane was associated with downregulation of Iscu and Ndufa4, the target genes of miR‐210, suggesting that the miR‐210–ISCU/NDUFA4 axis may affect mitochondrial energy metabolism. Furthermore, metabolome analysis revealed activation of anaerobic glycolysis in miR‐210‐transfected cells, and consistent with this the secretion of lactate, the final metabolite of anaerobic glycolysis, was significantly increased. Lactate concentration was higher in the kidney cortex of transgenic mice relative to wild‐type mice, although the difference was not significant (p = 0.070). On the basis of these findings, we propose that miR‐210 may induce a shift of energy metabolism from OxPhos to glycolysis by acting on the mitochondrial inner membrane. In addition to activation of glycolysis, we observed activation of the pentose phosphate pathway (PPP) and an increase in the total amount of amino acids in miR‐210‐transfected cells. This may help cells synthesize nucleotides and proteins for building new cells. These results suggest that miR‐210 may be involved in the metabolic changes in the early stage of ccRCC development, helping the cancer cells to acquire growth and survival advantages. © 2020 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.Keywords
Funding Information
- Japan Society for the Promotion of Science (KAKENHI Grant Number JP24590485)
- Ministry of Education, Culture, Sports, Science and Technology (KAKENHI Grant Number JP21790389)
This publication has 48 references indexed in Scilit:
- NDUFA4 Mutations Underlie Dysfunction of a Cytochrome c Oxidase Subunit Linked to Human Neurological DiseaseCell Reports, 2013
- MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell linesCell Death & Disease, 2013
- Metabolomic profiling of lung and prostate tumor tissues by capillary electrophoresis time-of-flight mass spectrometryMetabolomics, 2012
- Links between metabolism and cancerGenes & Development, 2012
- MicroRNA-210 Regulates Cancer Cell Proliferation through Targeting Fibroblast Growth Factor Receptor-like 1 (FGFRL1)Journal of Biological Chemistry, 2011
- miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activityCell Death & Differentiation, 2010
- Q's next: the diverse functions of glutamine in metabolism, cell biology and cancerOncogene, 2009
- MicroRNA-210 Controls Mitochondrial Metabolism during Hypoxia by Repressing the Iron-Sulfur Cluster Assembly Proteins ISCU1/2Cell Metabolism, 2009
- MicroRNA-210 Modulates Endothelial Cell Response to Hypoxia and Inhibits the Receptor Tyrosine Kinase Ligand Ephrin-A3Journal of Biological Chemistry, 2008
- The functions of animal microRNAsNature, 2004